NDC 65862-861 – Darifenacin
Darifenacin Hydrobromide 7.5 mg/1 · Tablet, Film Coated, Extended Release · Oral
Product NDC65862-861
Product details
- Brand name
- Darifenacin
- Generic name
- Darifenacin
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA206743
- Marketed since
- September 19, 2016
- Listing expires
- December 31, 2026
- Pharmacologic class
- Cholinergic Muscarinic Antagonist
Active ingredients
- Darifenacin Hydrobromide 7.5 mg/1
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 65862-861-05 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-861-05) | Sep 19, 2016 |
| 65862-861-30 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-861-30) | Sep 19, 2016 |
| 65862-861-90 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-861-90) | Sep 19, 2016 |
| 65862-861-99 | 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (65862-861-99) | Sep 19, 2016 |
Other Darifenacin products
- 65862-862 Darifenacin Hydrobromide 15 mg/1 · Tablet, Film Coated, Extended Release · Aurobindo Pharma Limited
- 16571-767 Darifenacin Hydrobromide 7.5 mg/1 · Tablet, Film Coated, Extended Release · Rising Pharma Holdings, Inc.
- 16571-768 Darifenacin Hydrobromide 15 mg/1 · Tablet, Film Coated, Extended Release · Rising Pharma Holdings, Inc.
- 62332-223 Darifenacin Hydrobromide 7.5 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.
- 62332-224 Darifenacin Hydrobromide 15 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Inc.
- 46708-223 Darifenacin Hydrobromide 7.5 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Limited
- 46708-224 Darifenacin Hydrobromide 15 mg/1 · Tablet, Extended Release · Alembic Pharmaceuticals Limited
- 72162-2570 Darifenacin Hydrobromide 7.5 mg/1 · Tablet, Extended Release · Bryant Ranch Prepack
- 72162-2571 Darifenacin Hydrobromide 15 mg/1 · Tablet, Extended Release · Bryant Ranch Prepack
- 69097-431 Darifenacin Hydrobromide 7.5 mg/1 · Tablet, Extended Release · Cipla USA Inc.
- 69097-432 Darifenacin Hydrobromide 15 mg/1 · Tablet, Extended Release · Cipla USA Inc.
- 33342-276 Darifenacin Hydrobromide 7.5 mg/1 · Tablet, Extended Release · Macleods Pharmaceuticals Limited